<table id="ID258" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 4. Established and Other Potentially Significant Drug Interactions</caption>
<col width="28%"></col>
<col width="22%"></col>
<col width="50%"></col>
<tfoot>
<tr>
<td align="left" colspan="3">
<paragraph stylecode="Footnote">↓ = Decreased (induces lamotrigine glucuronidation). <br/>
</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="3">
<paragraph stylecode="Footnote">↑ = Increased (inhibits lamotrigine glucuronidation). <br/>
</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="3">
<paragraph stylecode="Footnote">? = Conflicting data. <br/>
</paragraph>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="bottom">Concomitant Drug <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="bottom">Effect on Concentration<br/>of Lamotrigine or<br/>Concomitant Drug<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="bottom">Clinical Comment <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Estrogen-containing oral <br/>contraceptive preparations<br/>containing 30 mcg <br/>ethinylestradiol and 150 mcg<br/>levonorgestrel <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine <br/>
<br/>
<br/>↓ levonorgestrel <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine levels <br/>approximately 50%. <br/>
<br/>Decrease in levonorgestrel <br/>component by 19%. <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Carbamazepine and<br/>carbamazepine epoxide <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine <br/>
<br/>
<br/>? carbamazepine<br/>  epoxide <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Addition of carbamazepine <br/>decreases lamotrigine <br/>concentration approximately 40%. <br/>May increase carbamazepine<br/>epoxide levels. <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Phenobarbital/Primidone <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine <br/>concentration approximately 40%. <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Phenytoin <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine <br/>concentration approximately 40%. <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Rifampin <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine <br/>AUC approximately 40%. <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Valproate <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↑ lamotrigine <br/>
<br/>
<br/>? valproate <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Increased lamotrigine <br/>concentrations slightly more than <br/>2-fold. <br/>Decreased valproate concentrations <br/>an average of 25% over a 3-week <br/>period then stabilized in healthy <br/>volunteers; no change in controlled <br/>clinical trials in epilepsy patients. <br/>
</td>
</tr>
</tbody>
</table>